Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomoko Hata

Showing results (31-40 of 101) with videos related to

Pageof 11
Sort By:
Cancer Science|October 17, 2015
Phase I trial of volasertib, a Polo-like kinase inhibitor, in Japanese patients with acute myeloid leukemiaYukio Kobayashi, Takahiro Yamauchi, Hitoshi Kiyoi, et al.
International Journal of Hematology|September 12, 2014
Treatment outcome of elderly patients with aggressive adult T cell leukemia-lymphoma: Nagasaki University Hospital experienceJunya Makiyama, Yoshitaka Imaizumi, Hideki Tsushima, et al.
International Journal of Hematology|October 1, 2011
Allogeneic hematopoietic stem cell transplantation for ATL with central nervous system involvement: the Nagasaki transplant group experienceTakuya Fukushima, Jun Taguchi, Yukiyoshi Moriuchi, et al.
International Journal of Hematology|November 11, 2008
Successful cord blood transplantation for mycosis fungoidesTakuya Fukushima, Kensuke Horio, Emi Matsuo, et al.
International Journal of Hematology|April 14, 2018
EPOCH regimen as salvage therapy for adult T-cell leukemia-lymphomaEo Toriyama, Yoshitaka Imaizumi, Hiroaki Taniguchi, et al.
International Journal of Hematology|December 12, 2018
Complete remission of pure white cell aplasia associated with thymoma after thymectomy and cyclosporine administrationYuji Kobayashi, Koji Ando, Tomoko Hata, et al.
International Journal of Hematology|July 23, 2018
Clinical factors to predict outcome following mogamulizumab in adult T-cell leukemia-lymphomaJun Nakashima, Yoshitaka Imaizumi, Hiroaki Taniguchi, et al.
Leukemia Research|December 22, 2009
Differences in the distribution of subtypes according to the WHO classification 2008 between Japanese and German patients with refractory anemia according to the FAB classification in myelodysplastic syndromesAkira Matsuda, Ulrich Germing, Itsuro Jinnai, et al.
The Journal of Biological Chemistry|July 24, 2004
Skeletal muscle FOXO1 (FKHR) transgenic mice have less skeletal muscle mass, down-regulated Type I (slow twitch/red muscle) fiber genes, and impaired glycemic controlYasutomi Kamei, Shinji Miura, Miki Suzuki, et al.
International Journal of Hematology|March 14, 2013
Feasibility of cord blood transplantation in chemosensitive adult T-cell leukemia/lymphoma: a retrospective analysis of the Nagasaki Transplantation NetworkTakuya Fukushima, Hidehiro Itonaga, Yukiyoshi Moriuchi, et al.
Pageof 11

Showing results (31-40 of 101) with videos related to

Sort By:
Pageof 11
Cancer Science|October 17, 2015
Phase I trial of volasertib, a Polo-like kinase inhibitor, in Japanese patients with acute myeloid leukemiaYukio Kobayashi, Takahiro Yamauchi, Hitoshi Kiyoi, et al.
International Journal of Hematology|September 12, 2014
Treatment outcome of elderly patients with aggressive adult T cell leukemia-lymphoma: Nagasaki University Hospital experienceJunya Makiyama, Yoshitaka Imaizumi, Hideki Tsushima, et al.
International Journal of Hematology|October 1, 2011
Allogeneic hematopoietic stem cell transplantation for ATL with central nervous system involvement: the Nagasaki transplant group experienceTakuya Fukushima, Jun Taguchi, Yukiyoshi Moriuchi, et al.
International Journal of Hematology|November 11, 2008
Successful cord blood transplantation for mycosis fungoidesTakuya Fukushima, Kensuke Horio, Emi Matsuo, et al.
International Journal of Hematology|April 14, 2018
EPOCH regimen as salvage therapy for adult T-cell leukemia-lymphomaEo Toriyama, Yoshitaka Imaizumi, Hiroaki Taniguchi, et al.
International Journal of Hematology|December 12, 2018
Complete remission of pure white cell aplasia associated with thymoma after thymectomy and cyclosporine administrationYuji Kobayashi, Koji Ando, Tomoko Hata, et al.
International Journal of Hematology|July 23, 2018
Clinical factors to predict outcome following mogamulizumab in adult T-cell leukemia-lymphomaJun Nakashima, Yoshitaka Imaizumi, Hiroaki Taniguchi, et al.
Leukemia Research|December 22, 2009
Differences in the distribution of subtypes according to the WHO classification 2008 between Japanese and German patients with refractory anemia according to the FAB classification in myelodysplastic syndromesAkira Matsuda, Ulrich Germing, Itsuro Jinnai, et al.
The Journal of Biological Chemistry|July 24, 2004
Skeletal muscle FOXO1 (FKHR) transgenic mice have less skeletal muscle mass, down-regulated Type I (slow twitch/red muscle) fiber genes, and impaired glycemic controlYasutomi Kamei, Shinji Miura, Miki Suzuki, et al.
International Journal of Hematology|March 14, 2013
Feasibility of cord blood transplantation in chemosensitive adult T-cell leukemia/lymphoma: a retrospective analysis of the Nagasaki Transplantation NetworkTakuya Fukushima, Hidehiro Itonaga, Yukiyoshi Moriuchi, et al.
Pageof 11